Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-515 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
filingDate |
2000-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2005-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e736836d8c33aabfea7a01f0e8191a85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b53887125fa6f55b14689f6737977ce3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47c86b3ced29bd4705d55a293594cac8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a912325135852ddc2834b1005a4e2c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e09160143ff4a2d7ee757eff09b26fce |
publicationDate |
2005-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6884410-B1 |
titleOfInvention |
Methods for modulating antigen-specific immune responses |
abstract |
Interleukin-10 for producing a population of cells which are capable of inhibiting or suppressing reactions to alloantigens, for example in graft-versus-host disease or tissue rejection, is described. Interleukin-10 for reducing responses in mixed lymphocyte response (MLR) is also described. Exogenous or induced endogenous IL-10 may be used for the inhibition or suppression of the reactions to alloantigens. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007275005-A1 |
priorityDate |
1992-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |